The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2013
Filed:
Apr. 26, 2007
Vivian Huerta Galindo, Havana, CU;
Glay Chinea Santiago, Havana, CU;
Noralvis Fleitas Salazar, Havana, CU;
Alejandro Miguel Martin Dunn, Havana, CU;
Monica Sarria Nunez, Havana, CU;
Osmany Guirola Cruz, Havana, CU;
Patricia Gabriela Toledo Mayora, Havana, CU;
Aniel Sanchez Puente, Havana, CU;
Vladimir Armando Besada Perez, Havana, CU;
Osvaldo Reyes Acosta, Havana, CU;
Hilda Elisa Garay Perez, Havana, CU;
Ania Cabrales Rico, Havana, CU;
Alexis Musacchio Lasa, Havana, CU;
Gabriel Ramon Padron Palomares, Havana, CU;
Luis Javier Gonzalez Lopez, Havana, CU;
Vivian Huerta Galindo, Havana, CU;
Glay Chinea Santiago, Havana, CU;
Noralvis Fleitas Salazar, Havana, CU;
Alejandro Miguel Martin Dunn, Havana, CU;
Monica Sarria Nunez, Havana, CU;
Osmany Guirola Cruz, Havana, CU;
Patricia Gabriela Toledo Mayora, Havana, CU;
Aniel Sanchez Puente, Havana, CU;
Vladimir Armando Besada Perez, Havana, CU;
Osvaldo Reyes Acosta, Havana, CU;
Hilda Elisa Garay Perez, Havana, CU;
Ania Cabrales Rico, Havana, CU;
Alexis Musacchio Lasa, Havana, CU;
Gabriel Ramon Padron Palomares, Havana, CU;
Luis Javier Gonzalez Lopez, Havana, CU;
Centro de Ingenieria Genetica y Biotecnologia, Ciudad de La Habana, CU;
Abstract
The present invention is related to a method for blocking the infection of cells by dengue virus, based on interfering the direct interaction of the viral envelope protein with a cellular receptor or its indirect interaction with said cellular receptor through a carrier protein, as well as related uses; wherein said cellular receptor is the alpha-2 macroglobulin receptor, also known as the low density receptor-related protein or as CD91, and said carrier protein is human alpha-2 macroglobulin.